ZNF705EP: A Potential Drug Target and Biomarker (G100131539)
ZNF705EP: A Potential Drug Target and Biomarker
ZNF705EP (Zinc Finger Nucleotide-conjugated Enoyl-CoA Synthase 705-expression) is a gene that encodes a protein involved in the synthesis of essential amino acids, enamelids, and bile acids. The encoded protein, ZNF705EP, has been shown to play a crucial role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, ZNF705EP has potential as a drug target or biomarker.
The ZNF705EP Protein
ZNF705EP is a 21-kDa protein that belongs to the ZNF gene family. The ZNF gene is located on chromosome 6p21 and has been implicated in various cellular processes, including cell growth, differentiation, and DNA repair. ZNF705EP is composed of 1,947 amino acids and has a calculated pI of 11.95.
The ZNF705EP protein has several unique features that make it an attractive drug target or biomarker. One of its most noteworthy features is its ability to interact with various signaling pathways, including TOR, PI3K, and NF-kappa-B. ZNF705EP has been shown to play a role in these signaling pathways and is involved in the regulation of various cellular processes, including cell growth, differentiation, and inflammation.
In addition to its involvement in signaling pathways, ZNF705EP is also known for its role in the regulation of cellular gene expression. Studies have shown that ZNF705EP can physically interact with various DNA-protein complexes, including p53, and can modulate the activity of these complexes. This suggests that ZNF705EP may play a role in the regulation of cellular gene expression and may be a potential drug target.
The Potential Benefits of ZNF705EP as a Drug Target
If ZNF705EP is successfully targeted as a drug, it has the potential to treat a variety of diseases. One of the most promising applications of ZNF705EP as a drug is its potential to treat cancer. Cancer is a leading cause of death worldwide, and there is a significant need for new, effective treatments. ZNF705EP has been shown to play a role in the regulation of cell growth and has been shown to inhibit the growth of cancer cells in cell culture.
In addition to its potential to treat cancer, ZNF705EP has also the potential to treat neurodegenerative diseases. Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are characterized by the progressive loss of brain cells and can have a significant impact on an individual's quality of life. ZNF705EP has been shown to play a role in the regulation of cellular processes that are involved in the development and progression of neurodegenerative diseases.
Another potential application of ZNF705EP as a drug is its potential to treat autoimmune disorders. Autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis, are characterized by the immune system attacking the body's own tissues. ZNF705EP has been shown to play a role in the regulation of cellular processes that are involved in the development and progression of autoimmune disorders.
The Potential Risks of ZNF705EP as a Drug
While ZNF705EP has the potential to treat a variety of diseases, there are also several potential risks associated with its use as a drug. One of the most significant risks is its potential to cause adverse side effects. The exact nature
Protein Name: Zinc Finger Protein 705E, Pseudogene
Functions: May be involved in transcriptional regulation
The "ZNF705EP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF705EP comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836
